---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-030531"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-08-29T23:59:59+00:00"
generated_at: "2026-06-11T02:17:52.979470+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CMS denies Medicare/Medicaid reimbursement for NanoVibronix PainShield device

## Summary
- CMS concluded PainShield does not fall within DMEPOS benefit category, so not reimbursable under Medicare/Medicaid.
- CEO Brian Murphy says company plans to develop action plan and resubmit application for additional CMS review.
- Company continues distribution in workers' comp, personal injury, and VA markets while addressing CMS concerns.
- NanoVibronix believes PainShield benefits over 150M Medicare/Medicaid patients but faces reimbursement setback.

## SEC filing metadata
- accession: 0001493152-23-030531
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-08-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223030531/0001493152-23-030531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223030531/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-030531
- JSON: https://secwatch.observer/filing/0001493152-23-030531.json
- Plain text: https://secwatch.observer/filing/0001493152-23-030531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.